Hims & Hers Withdraws Knockoff Weight-Loss Pill After Regulatory Scrutiny
The New York Times • • business
Key Points:
- Hims & Hers announced it will stop selling a low-cost knockoff of Novo Nordisk’s weight loss pill Wegovy following pressure from federal regulators.
- The company had launched the pill version on Thursday but faced immediate backlash regarding its legality.
- The Department of Health and Human Services referred Hims to the Justice Department for possible violations of federal medication sale laws.
- Hims cited “constructive conversations with stakeholders” as the reason for discontinuing the product.
